Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers
DOI: https://doi.org/10.2147/ott.s461430
IF: 4
2024-06-05
OncoTargets and Therapy
Abstract:Mincheol Chae, 1, &ast Jae-Ho Lee, 2, &ast Jong Ho Park, 2 Dong Yoon Keum, 1 Hanna Jung, 3 Youngok Lee, 3 Deok Heon Lee 3 1 Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea; 2 Department of Anatomy, Keimyung University School of Medicine, Daegu, Korea; 3 Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Jung-gu, 41944, Korea &astThese authors contributed equally to this work Correspondence: Deok Heon Lee, Tel +82-53-200-5665, Fax +82-53-426-4765, Email Background: TRF1, TRF2, and TERT (Telomerase reverse transcriptase) are telomere-associated factors that regulate telomere length. Genetic changes in these genes may be associated with cancer pathogenesis; however, this relationship has not yet been comprehensively elucidated in lung cancer. Aim: : Exploring the clinicopathologic and prognostic values of TRF1, TRF2, and TERT mRNA expression in non-small cell lung cancers (NSCLC). Methods: : The clinical significance of TRF1, TRF2, and TERT expression in 141 patients with NSCLC was investigated. Additionally, these findings were supported by the open big data from The Cancer Genome Atlas (TCGA). Results: : TRF1 and TRF2 expression levels tended to be associated with smoking, and TERT expression was positively correlated with age. The survival analysis showed that TRF1 expression predicted a better prognosis for squamous cell carcinoma (SCC), whereas TRF2 expression was associated with a shorter survival in adenocarcinoma. TCGA data also showed a better prognosis for SCC with TRF1 expression. However, the TRF2 results were not in agreement with our data. Conclusions: : We present the clinical and prognostic values of TRF1, TRF2, and TERT expression in NSCLC tissues and TCGA. Our findings suggest that TRF1 expression is a possible prognostic marker for NSCLC, particularly SCC. Keywords: TRF1, TRF2, TERT, telomere, lung cancer Telomeres, comprised of TTAGGG repeat sequences, are nucleoprotein complexes that cap the ends of eukaryotic chromosomes. 1 Telomeres in normal somatic cells are shortened by approximately 0–200 base pairs at every cell division and have a critical length at which replicative senescence or apoptosis is initiated. 2,3 Therefore, the regulation of telomeres within an optimal length is essential for cell survival. 1–3 In cancer cells, preneoplastic or early stage of cancer cell suffer persistent telomere shortening leading to senescence, and then, this status is counteracted by the reverse transcriptase telomerase, whereas the remaining cells maintain telomere length via an alternative lengthening mechanism. 4,5 TRF1, TRF2, and TERT (Telomerase reverse transcriptase) are telomere-associated proteins that are part of the telomere structure and play essential roles in controlling telomere length. 6–8 TRF1 is a suppressor of telomere elongation. 6 TRF1 and TRF2 bind specifically to double-stranded TTAGGG repeats in the telomere. TRF2 is also a negative regulator of telomere length. 9 Therefore, overexpression of TRF2 results in progressive shortening of telomere length, similar to TRF1 overexpression. TERT is a ribonucleoprotein polymerase that maintains the telomere ends. 10 Its high expression sustains telomere length and genomic stability, thereby allowing cancer cells to divide continuously and preventing senescence or apoptosis. 11,12 To clarify the role of telomere regulation in cancer, mRNA expressions of TRF1, TRF2, and TERT should be comprehensively studied. Lung cancer is the leading cause of cancer-related deaths worldwide, with only 21% of lung cancer patients alive five years after diagnosis. 13 Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 85% of all cases. 14 Many causative factors for lung cancer have been identified, including active smoking, secondhand smoke, occupational agents, radiation, and environmental pollutants. 15 They may influence telomere regulation in human disease especially in NSCLC. Previous studies have suggested that deregulation of telomere length has the potential to serve as a prognostic marker in patients with NSCLC. 14,16 Therefore, we analyzed, for the first time, the clinical value of telomere regulatory genes in NSCLC. Recent advances in genomic profiling using next-generation sequencing have made it possible to identify the genetic characteristics -Abstract Truncated-
oncology,biotechnology & applied microbiology